在住院成人2型糖尿病患者中使用持续葡萄糖监测与常规护理进行强化血糖管理的随机试验结果:TIGHT研究
在六家学术医院的非重症监护住院2型糖尿病患者中,随机分为常规治疗组(血糖目标140-180 mg/dL)和CGM引导的强化治疗组(血糖目标90-130 mg/dL)。主要结局CGM平均葡萄糖强化组170 mg/dL vs 常规组175 mg/dL(风险调整差值-7 mg/dL,95%CI -19至5;P=0.25),仅7%强化组达到90-130 mg/dL目标。结论:CGM引导的血糖管理方法未改善血糖水平,90-130 mg/dL目标在当前胰岛素管理环境下可能不现实。
要点
- CGM引导强化组平均葡萄糖170 mg/dL vs 常规组175 mg/dL,差值未达统计学显著(95%CI -19至5;P=0.25)。
- 仅7%强化组达到90-130 mg/dL平均葡萄糖目标范围。
- CGM读数<54 mg/dL罕见:强化组0.2% vs 常规组0.4%,调整差值-0.1%(95%CI -0.6至0.3)。
核心结论
- 使用CGM的血糖管理方法与非重症监护住院环境下的标准血糖管理相比未改善血糖水平。
- 90-130 mg/dL的血糖目标在当前医院胰岛素管理环境下可能不现实。
研究设计与样本
- 六家学术医院、非重症监护住院的成人2型糖尿病患者随机分配至标准治疗组(血糖目标140-180 mg/dL)或CGM引导的强化治疗组(血糖目标90-130 mg/dL)。
- 主要分析纳入110例参与者,平均±SD年龄61±12岁,平均HbA1c 8.9±2.3%(73.8±1.6 mmol/mol)。
- 强化组n=60,标准组n=50;主要结局为CGM测定的平均葡萄糖(标准组CGM为盲法)。
- 关键次要结局为CGM葡萄糖<54 mg/dL。
主要发现
- CGM测定的平均葡萄糖强化组170 mg/dL vs 标准组175 mg/dL(风险调整差值-7 mg/dL,95%CI -19至5;P=0.25)。
- 仅7%的强化组达到90-130 mg/dL的平均葡萄糖目标范围。
- CGM读数<54 mg/dL罕见:强化组0.2% vs 标准组0.4%(调整治疗组差值-0.1%,95%CI -0.6至0.3)。
- 标准组发生1例严重低血糖事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether continuous glucose monitoring (CGM) could assist providers in intensifying glycemic management in hospitalized patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: At six academic hospitals, adults with type 2 diabetes hospitalized in a non-intensive care setting were randomly assigned to either standard therapy with glucose target 140-180 mg/dL (standard group) or intensive therapy with glucose target 90-130 mg/dL guided by CGM (intensive group). The primary outcome was mean glucose measured with CGM (blinded in standard group), and the key secondary outcome was CGM glucose <54 mg/dL. RESULTS: For the 110 participants included in the primary analysis, mean ± SD age was 61 ± 12 years and mean HbA1c was 8.9 ± 2.3% (73.8 ± 1.6 mmol/mol). During the study, CGM-measured mean glucose was 170 mg/dL for the intensive group (n = 60) vs. 175 mg/dL for the standard group (n = 50; risk-adjusted difference -7 mg/dL, 95% CI -19 to 5; P = 0.25). Only 7% of the intensive group achieved the mean glucose target range of 90-130 mg/dL. CGM readings <54 mg/dL were infrequent (0.2% for intensive and 0.4% for standard; adjusted treatment group difference -0.1%, 95% CI -0.6 to 0.3). One severe hypoglycemia event occurred in the standard group. CONCLUSIONS: The study's glucose management approach using CGM did not improve glucose levels compared with standard glucose management in the non-intensive care unit hospital setting. A glucose target of 90-130 mg/dL may not be realistic in the current environment of insulin management in the hospital.
引用
- Hirsch IB, Draznin B, Buse JB, et al. Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study. Diabetes Care. 2025. PMID: 39571106. doi:10.2337/dc24-1779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。